Direct access to our audited, enterprise-scale CRO & CDMO botanical service lines and manufacturing pipelines.
In modern phytochemical manufacturing, global regulatory bodies—including the US FDA (21 CFR Part 111 & Botanical Drug Guidance), EFSA, and EMA—demand absolute chromatographic repeatability, precise fingerprint profiling, and unequivocal safety substantiation. The paradigm has shifted entirely from bulk powdered herbs to standardized, bioavailable bioactive fractions.
As premier Chinese natural herbs and formulation manufacturers, MedGence (Yineng Pharma) bridges ancient phytotherapy and molecular pharmacology. By employing high-performance liquid chromatography (HPLC), high-performance thin-layer chromatography (HPTLC), and gas chromatography-mass spectrometry (GC-MS), our operations eliminate inherent agricultural fluctuations, providing global brand partners with dependable chemical specifications.
Navigating varying intercontinental compliance protocols. We formulate directly within the frameworks of DSHEA, EU Novel Food authorizations, and TGA Australian standards, preventing costly product border detentions.
Discarding non-specific extract ratios (e.g. generic 10:1) in favor of verified active compound density. We isolate marker compounds including ginsenosides, polyphenols, flavonoids, and active alkaloids.
Industrial supercritical CO2 extraction and membrane molecular filtration designed to rigorously strip heavy metals, organochlorine pesticide residues, polycyclic aromatic hydrocarbons (PAHs), and aflatoxins.
Operating out of Changsha, Hunan—a primary hub for agricultural innovation and traditional botanical medicine—our production nexus exploits an unmatched geographical, intellectual, and logistical infrastructure.
Our raw botanical supply chain relies on localized cultivation partnerships ("Daodi" regions). We analyze soil conditions, harvesting seasons, and environmental altitudes to maximize natural secondary metabolite concentrations.
Bridging the notorious "valley of death" between laboratory assay validation and metric-ton industrial output. Our pilot facility models thermodynamic yields, ensuring uninterrupted scale-up with zero compound degradation.
Operating under strict bilateral NDAs and segregated clean-room synthesis lanes. Your custom herbal blends, extraction parameters, and formulation ratios remain exclusively your proprietary competitive intellectual property.
Phytochemical extraction is shifting toward precision molecular engineering. MedGence integrates high-throughput artificial intelligence screening with advanced pharmaceutical delivery systems to overcome traditional limitations like bioavailability and gastrointestinal degradation.
Utilizing molecular docking simulations and bioinformatics to map botanical compounds against human target receptors, identifying synergistic ingredient networks prior to in vitro testing.
Transitioning away from petroleum-based solvents. Deploying continuous ultrasonic countercurrent extraction and enzymatic pre-treatments that maximize purity while reducing carbon intensity.
Developing liposomal, phytosome, and solid dispersion delivery matrices for hydrophobic botanicals (e.g., curcumin, berberine, quercetin) to increase systemic bioavailability up to 800%.
Conducting randomized, double-blind, placebo-controlled human clinical trials (Phase I-IV) to provide substantiated structure/function claims approved by the FTC, FDA, and EFSA.
Our formulation engineering team customizes physical properties, dissolution rates, organoleptic attributes, and chemical stability profiles to suit distinct industry applications.
High-potency botanical extracts formulated into delayed-release veggie capsules, moisture-barrier softgels, and multi-layer tablets designed for gut health, metabolic regulation, and cognitive longevity.
Micro-encapsulated, cold-water-soluble botanical powders exhibiting zero astringency, thermal stability, and immediate clarity, tailored for sachets, ready-to-drink (RTD) beverages, and effervescent delivery.
Sterilized, low-color, odor-neutral plant extracts standardized for transdermal penetration. Designed for clinically validated anti-inflammatory, cellular antioxidant, and skin-barrier reinforcement lines.
A formula is only as viable as its legal clearance. As an international OEM/CDMO partner, we mitigate regulatory and operational friction across destination markets.
We provide full Common Technical Document (CTD) formats, Stability Study Reports (accelerated and long-term according to ICH guidelines), Method Validation Reports, and Certificates of Analysis (CoA).
Facilities aligned with cGMP, ISO 22000, HACCP, Halal, and Kosher certifications. Routine rigorous third-party auditing guarantees seamless import clearance through EU and North American customs.
Flexible batch sizes, bonded warehousing strategies, cold-chain logistical integration, and rapid localized re-testing protocols to ensure just-in-time delivery for brand packaging facilities globally.
Over a decade of trusted collaborations with domestic and international medical research centers, tertiary healthcare institutions, and publicly traded pharmaceuticals.
Tongrentang Group
CR Sanjiu
Sunflower Pharma
Livzon Pharma
Dihon Pharma
Golden Throat
Yangtzi River Pharma
Gofar Chuanshan
Humanwell Healthcare
SCIMYTH Pharma
Hanfang Pharma
Luoxin Pharma
Zhongsheng Pharma
Brilliance & Abundance
Apeloa Pharma
Heng Chang Pharma
Baotou TCM
Kamp Medicine
In-depth responses resolving engineering, chemical validation, regulatory clearance, and commercial supply chain inquiries.
Select a specialized capability to initiate sample requests, method development briefs, or contract manufacturing estimations.
